Desiderio D M, Zhan X
The Charles B. Stout Neuroscience Mass Spectrometry Laboratory, The University of Tennessee Health Science Center, 847 Monroe Avenue, Room 117, Memphis, TN 38163, USA.
Cell Mol Biol (Noisy-le-grand). 2003 Jul;49(5):689-712.
In order to clarify the basic molecular mechanisms that participate in the formation of human pituitary macroadenomas, this study, for the first time, describes the comparative proteomics between a pituitary adenoma tissue and a control tissue. A vertical, two-dimensional polyacrylamide gel electrophoresis system and PDQuest image analysis software were used to provide a high level of between-gel reproducibility and electrophoretic separation to accurately locate each differentially expressed protein. Mass spectrometry (MALDI-TOF and LC-ESI-Q-IT) and protein databases were used to characterize each differentially expressed protein. A total of 137 differential gel spots (37 increased spot volumes, 39 decreased, 19 new and 42 lost) were found when we compared an adenoma proteome to a control proteome. Seventy-one spots (20 increased, 27 decreased, 13 new, 11 lost), representing 39 differentially regulated proteins, were identified. Five differentially regulated proteins (prolactin, cellular retinoic acid-binding protein II, G-protein beta subunit 3, secretagogin and calreticulin) were also validated with results from a comparative transcriptomics study of pituitary adenomas and controls. The functional characteristics of these differentially expressed proteins provide a differential proteomic profile between a pituitary adenoma and a control.
为了阐明参与人类垂体大腺瘤形成的基本分子机制,本研究首次描述了垂体腺瘤组织与对照组织之间的比较蛋白质组学。使用垂直二维聚丙烯酰胺凝胶电泳系统和PDQuest图像分析软件,以提供高水平的凝胶间重现性和电泳分离,从而准确地定位每个差异表达的蛋白质。利用质谱分析(基质辅助激光解吸电离飞行时间质谱和液相色谱-电喷雾离子阱质谱)和蛋白质数据库对每个差异表达的蛋白质进行表征。当我们将腺瘤蛋白质组与对照蛋白质组进行比较时,共发现137个差异凝胶点(37个斑点体积增加,39个减少,19个新增,42个消失)。鉴定出71个斑点(20个增加,27个减少,13个新增,11个消失),代表39种差异调节的蛋白质。垂体腺瘤与对照的比较转录组学研究结果也验证了5种差异调节的蛋白质(催乳素、细胞视黄酸结合蛋白II、G蛋白β亚基3、分泌粒蛋白和钙网蛋白)。这些差异表达蛋白质的功能特征提供了垂体腺瘤与对照之间的差异蛋白质组学图谱。